SHL logo

Siemens Healthineers AG Stock Price

XTRA:SHL Community·€43.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 71 Fair Values set on narratives written by author

SHL Share Price Performance

€0
-47.37 (-100.00%)
€45.65
Fair Value
€0
-47.37 (-100.00%)
Price €0

SHL Community Narratives

·
Fair Value €45.65 13.4% undervalued intrinsic discount

AI Diagnostics Partnerships And Healthcare Demand Will Support Global Expansion Ahead

2users have liked this narrative
0users have commented on this narrative
36users have followed this narrative
·
Fair Value €36 9.8% overvalued intrinsic discount

Future Tariff Headwinds And AI Adoption Will Shape Long Term Healthcare Technology Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value €56.35 29.9% undervalued intrinsic discount

Undervalued Healthcare Leader Will Benefit From Rising Noncommunicable Disease Demand Long Term

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

SHL logo

SHL: Future Returns Will Hinge On Diagnostics Margin Pressure Risk

Fair Value: €36 9.8% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SHL logo

SHL: Future Margin Delivery Looks Set To Support Upper P E Range

Fair Value: €56.35 29.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
SHL logo

SHL: Margin Execution And Cyber Resilience Will Support Future Multiple Expansion

Fair Value: €45.65 13.4% undervalued intrinsic discount
36 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with excellent balance sheet.

1 Risk
4 Rewards

Siemens Healthineers AG Key Details

€23.2b

Revenue

€14.1b

Cost of Revenue

€9.0b

Gross Profit

€6.8b

Other Expenses

€2.2b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 05, 2026
1.99
39.02%
9.55%
75.7%
View Full Analysis

About SHL

Founded
1896
Employees
74300
CEO
Bernhard Montag
WebsiteView website
www.siemens-healthineers.com

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS to increase product lifecycle with industrial AI. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.

Recent SHL News & Updates

Narrative Update Aug 20

SHL: Future Returns Will Hinge On Diagnostics Margin Pressure Risk

Analysts now set a slightly lower central price target for Siemens Healthineers at €36 from €37, reflecting updated expectations for profit margins and valuation multiples following recent mixed revisions to Street targets that range from €37 to €57.40. Analyst Commentary Recent Street research on Siemens Healthineers points to a mixed but generally cautious backdrop.
Narrative Update Aug 06

SHL: Future Margin Delivery Looks Set To Support Upper P E Range

The analyst fair value estimate for Siemens Healthineers has shifted from €63.00 to about €56.35, reflecting updated assumptions on revenue growth, margins, discount rate and future P/E, alongside recent Street price target revisions clustered in the €37.00 to €57.40 range. Analyst Commentary Recent Street research on Siemens Healthineers shows a wide spread in views, although several bullish analysts remain constructive on the stock.

Recent updates

No updates